HLK Biotech Holding Group Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on HLK Biotech Holding Group's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Oil and Gas Industry Growth | 33.7% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Jun 1999 |
Recent past performance updates
No updates
Recent updates
No updates
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, HLK Biotech Holding Group has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses BreakdownBeta
How HLK Biotech Holding Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 99 | 0 | -1 | 1 | 0 |
Quality Earnings: Insufficient data to determine if AMHD has high quality earnings.
Growing Profit Margin: Insufficient data to determine if AMHD's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if AMHD's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare AMHD's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if AMHD's earnings growth over the past year exceeded the Oil and Gas industry average.
Return on Equity
High ROE: AMHD has a negative Return on Equity (0%), as it is currently unprofitable.